Irbesartan CAS 138402-11-6
Identification
Properties
Safety Data
Specifications & Other Information
Links
Identification
CAS Number
138402-11-6
Name
Irbesartan
Synonyms
1,3-Diazaspiro[4.4]non-1-en-4-one, 2-butyl-3-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]- [ACD/Index Name]
1,3-diazaspiro4.4non-1-en-4-one, 2-butyl-3-2′-(1H-tetrazol-5-yl)1,1′-biphenyl-4-ylmethyl-
138402-11-6 [RN]
2-Butyl-3-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-1,3-diazaspiro[4.4]non-1-en-4-one
2-Butyl-3-{[2′-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-on [German] [ACD/IUPAC Name]
2-Butyl-3-{[2′-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one [ACD/IUPAC Name]
2-Butyl-3-{[2′-(1H-tétrazol-5-yl)-4-biphénylyl]méthyl}-1,3-diazaspiro[4.4]non-1-én-4-one [French] [ACD/IUPAC Name]
2-Butyl-3-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-on [German]
2-butyl-3-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one
2-butyl-3-{[2′-(1H-tétrazol-5-yl)biphényl-4-yl]méthyl}-1,3-diazaspiro[4.4]non-1-én-4-one [French]
7229
Irbesartan [INN] [JAN] [USAN] [Wiki]
J0E2756Z7N
[3H]irbesartan
[138402-11-6]
1216883-23-6 [RN]
2-?BUTYL-?3-?[[2′-?(2H-?TETRAZOL-?5-?YL)[1,?1′-?BIPHENYL]-?4-?YL]METHYL]-?1,?3-?DIAZASPIRO[4.4]NON-?1-?EN-?4-?ONE
2-butyl-3-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1,3-diazaspiro[4.4]non-1-en-4-one
2-butyl-3-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1,3-diazaspiro[4.4]non-1-en-4-one
2-Butyl-3-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-1,3-diazaspiro(4.4)non-1-en-4-one
2-Butyl-3-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one
2-butyl-3-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one
2-Butyl-3-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one
2-butyl-3-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one
2-butyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one
2-Butyl-3-[2′-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]1,3-diaza-spiro[4.4]non-1-en-4-one
2-Butyl-3-[2′-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-1,3-diaza-spiro[4.4]non-1-en-4-one
2-Butyl-3-[2′-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-1,3-diaza-spiro[4.4]non-1-en-4-one
2-butyl-3-{[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one
2-n-butyl-3-((2′-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1,3-diazaspiro(4,4)non-1-en-4-one
3-((2-(1h-tetrazol-5-yl)-[1,1-biphenyl]-4-yl)methyl)-2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one
3-((2-(1h-tetrazol-5-yl)-[1,1-biphenyl]-4-yl)-methyl)-2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one
3-((2′-(1H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methyl)-2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one
3-((2′-(1H-Tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)-methyl)-2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one
3-((2′-(2H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methyl)-2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one
3-((2′-(2H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one
3-((2`-(1H-Tetrazol-5-yl)-[1,1`-biphenyl]-4-yl)methyl)-2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one
3-butyl-2-((4-(2-(2h-tetrazol-5-yl)phenyl)phenyl)methyl)-2,4-diazaspiro(4.4)non-3-en-1-one
3-Butyl-2-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-2,4-diazaspiro[4.4]non-3-en-1-one
6620400 [Beilstein]
8-butyl-7-[[4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]-7,9-diazaspiro[4.4]non-8-en-6-one
8-butyl-7-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-7,9-diazaspiro[4.4]non-8-en-6-one
Aprovel
Aprovel®
Aprovel®|Avapro®|SR 47436
AVALIDE
Avapro [Wiki]
Avapro®
Avapro;SR-47436; BMS-186295
BMS-186295, SR-47436
BR-57149
C081309
C25H28N6O
HM2950270
irbesartan, ??? 98.0%
IRBESARTAN-D4
Irbesartan-d7
IRBESARTIN
Karvea
MFCD00864464 [MDL number]
MFCD18384966
Pharmakon1600-01504259
TL8000875
UNII:J0E2756Z7N
UNII-J0E2756Z7N
Molecular Structure

Structure of Irbesartan CAS 138402-11-6
SMILES
CCCCC1=NC2(CCCC2)C(=O)N1Cc3ccc(cc3)c4ccccc4c5[nH]nnn5
StdInChI
InChI=1S/C25H28N6O/c1-2-3-10-22-26-25(15-6-7-16-25)24(32)31(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,27,28,29,30)
StdInChIKey
YOSHYTLCDANDAN-UHFFFAOYSA-N
Molecular Formula
C25H28N6O
Molecular Weight
428.54
MDL Number
MFCD00864464
Safety Data
RIDADR
NONH for all modes of transport
WGK Germany
3
Specifications and Other Information of Our Irbesartan CAS 138402-11-6
Standard
Enterprise standard
GMP
CFDA
Basic Patent Situation
US expiry date | 20120330 |
EU expiry date | WITHDRAWN |
JP expiry date | 20160320 |
Package
According to customer requirements to packaging
Storage
Under the room temperature and away from light
Application
Used as the Angiotensin II Receptor Antagonist
Links
Watson International Ltd
This product is sold exclusively through our sales company Watson International Ltd, and please click the link below for details.
http://www.watson-int.com/irbesartan-cas-138402-11-6/